These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 11530737)

  • 1. Effect of genetic variation on the postprandial response. Results from the European Atherosclerosis Research Study II.
    Talmud PJ; Waterworth DM; Humphries SE;
    World Rev Nutr Diet; 2001; 89():53-60. PubMed ID: 11530737
    [No Abstract]   [Full Text] [Related]  

  • 2. [Interaction between genes and diet as a determinant of the plasma levels of cholesterol].
    López Miranda J; Ordovás JM; Pérez Jiménez F
    Med Clin (Barc); 1998 Oct; 111(14):546-51. PubMed ID: 9859082
    [No Abstract]   [Full Text] [Related]  

  • 3. Endothelial-derived lipoprotein lipase is bound to postprandial triglyceride-rich lipoproteins and mediates their hepatic clearance in vivo.
    Heeren J; Niemeier A; Merkel M; Beisiegel U
    J Mol Med (Berl); 2002 Sep; 80(9):576-84. PubMed ID: 12226739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of lipoprotein lipase and hepatic lipase on the transformation of VLDL and HDL during lipolysis of VLDL.
    Murdoch SJ; Breckenridge WC
    Atherosclerosis; 1995 Dec; 118(2):193-212. PubMed ID: 8770314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of the common apolipoprotein C-III (APOC3 -482C > T) and hepatic lipase (LIPC -514C > T) promoter variants affects glucose tolerance in young adults. European Atherosclerosis Research Study II (EARS-II).
    Jansen H; Waterworth DM; Nicaud V; Ehnholm C; Talmud PJ;
    Ann Hum Genet; 2001 May; 65(Pt 3):237-43. PubMed ID: 11427182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamics of C-apolipoproteins in the enzymatic interconversions of plasma lipoproteins.
    Kinnunen PK; Vainio P; Virtanen JA
    Ric Clin Lab; 1982; 12(1):41-9. PubMed ID: 7046022
    [No Abstract]   [Full Text] [Related]  

  • 7. Expression of type III hyperlipoproteinemia in patients homozygous for apolipoprotein E-2 is modulated by lipoprotein lipase and postprandial hyperinsulinemia.
    Brümmer D; Evans D; Berg D; Greten H; Beisiegel U; Mann WA
    J Mol Med (Berl); 1998 Apr; 76(5):355-64. PubMed ID: 9587070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic study of common variants at the Apo E, Apo AI, Apo CIII, Apo B, lipoprotein lipase (LPL) and hepatic lipase (LIPC) genes and coronary artery disease (CAD): variation in LIPC gene associates with clinical outcomes in patients with established CAD.
    Baroni MG; Berni A; Romeo S; Arca M; Tesorio T; Sorropago G; Di Mario U; Galton DJ
    BMC Med Genet; 2003 Sep; 4():8. PubMed ID: 12964943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chylomicronemia due to apolipoprotein CIII overexpression in apolipoprotein E-null mice. Apolipoprotein CIII-induced hypertriglyceridemia is not mediated by effects on apolipoprotein E.
    Ebara T; Ramakrishnan R; Steiner G; Shachter NS
    J Clin Invest; 1997 Jun; 99(11):2672-81. PubMed ID: 9169497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations of genotypes at the apolipoprotein AI-CIII-AIV, apolipoprotein B and lipoprotein lipase gene loci with coronary atherosclerosis and high density lipoprotein subclasses.
    Peacock RE; Hamsten A; Johansson J; Nilsson-Ehle P; Humphries SE
    Clin Genet; 1994 Oct; 46(4):273-82. PubMed ID: 7834891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory mutations in human lipoprotein disorders and atherosclerosis.
    Kontula K; Ehnholm C
    Curr Opin Lipidol; 1996 Apr; 7(2):64-8. PubMed ID: 8743897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein defects.
    Breslow JL
    Hosp Pract (Off Ed); 1985 Dec; 20(12):43-9. PubMed ID: 3934198
    [No Abstract]   [Full Text] [Related]  

  • 13. Interrelationships between postprandial lipoprotein B:CIII particle changes and high-density lipoprotein subpopulation profiles in mixed hyperlipoproteinemia.
    Saïdi Y; Sich D; Camproux A; Egloff M; Federspiel MC; Gautier V; Raisonnier A; Turpin G; Beucler I
    Metabolism; 1999 Jan; 48(1):60-7. PubMed ID: 9920146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Familial hypertriglyceridemia].
    Kuwasako T; Yamashita S
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():74-8. PubMed ID: 11347165
    [No Abstract]   [Full Text] [Related]  

  • 15. Mechanism of triglyceride lowering in mice expressing human apolipoprotein A5.
    Fruchart-Najib J; Baugé E; Niculescu LS; Pham T; Thomas B; Rommens C; Majd Z; Brewer B; Pennacchio LA; Fruchart JC
    Biochem Biophys Res Commun; 2004 Jun; 319(2):397-404. PubMed ID: 15178420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles.
    Aalto-Setälä K; Fisher EA; Chen X; Chajek-Shaul T; Hayek T; Zechner R; Walsh A; Ramakrishnan R; Ginsberg HN; Breslow JL
    J Clin Invest; 1992 Nov; 90(5):1889-900. PubMed ID: 1430212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The atherogenic plasma remnant-like particle cholesterol concentration is increased in the fasting and postprandial state in active acromegalic patients.
    Twickler TB; Dallinga-Thie GM; Zelissen PM; Koppeschaar HP; Erkelens DW
    Clin Endocrinol (Oxf); 2001 Jul; 55(1):69-75. PubMed ID: 11453954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional control of triglyceride metabolism: fibrates and fatty acids change the expression of the LPL and apo C-III genes by activating the nuclear receptor PPAR.
    Auwerx J; Schoonjans K; Fruchart JC; Staels B
    Atherosclerosis; 1996 Jul; 124 Suppl():S29-37. PubMed ID: 8831913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of recombinant wild type and site-directed mutations of apolipoprotein C-III: lipid binding, displacement of ApoE, and inhibition of lipoprotein lipase.
    Liu H; Talmud PJ; Lins L; Brasseur R; Olivecrona G; Peelman F; Vandekerckhove J; Rosseneu M; Labeur C
    Biochemistry; 2000 Aug; 39(31):9201-12. PubMed ID: 10924113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variation at the lipoprotein lipase and apolipoprotein AI-CIII gene loci are associated with fasting lipid and lipoprotein traits in a population sample from Iceland: interaction between genotype, gender, and smoking status.
    Peacock RE; Temple A; Gudnason V; Rosseneu M; Humphries SE
    Genet Epidemiol; 1997; 14(3):265-82. PubMed ID: 9181356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.